Retail store Walmart Inc (NYSE:WMT) on Thursday launched a series of community events to administer the COVID-19 vaccine across the country in partnership with local community leaders and nonprofit organizations and under CDC vaccine allocation.
Through the Federal Retail Pharmacy Programme, the company has announced ongoing community vaccination programme at 1,400 pharmacies nationwide in 35 states, Puerto Rico and Washington, DC. Vaccine supply and eligibility will vary based on state and local guidelines. The eligible customers can schedule a vaccine appointment at http://www.walmart.com/COVIDvaccine.
The community vaccine events will take place at 43 locations across 18 states, including drive-thru locations in Walmart parking lots, in-store and across several offsite locations in partnership with community organizations.
In addition, the company plans to continue these new events in Alabama, Colorado, Florida, Georgia, Idaho, Indiana, Louisiana, Minnesota, Mississippi, Missouri, Nevada, Oklahoma, Pennsylvania, South Dakota, Tennessee, Texas, Utah and Virginia.
Insilico Medicine and Tenacia expand AI-driven R&D collaboration
Eisai and Nuvation Bio report taletrectinib MAA validated by European regulator
Novo Nordisk's Awiqli once-weekly basal insulin treatment approved by US FDA
Kodiak Sciences reports positive Phase 3 results for Zenkuda in diabetic retinopathy
GC Biopharma secures first Latin American approval for BARYCELA Inj.
Clarity Pharmaceuticals signs copper-64 manufacturing agreement with Theragenics
Merck to acquire Terns Pharmaceuticals for USD6.7bn
Maze Therapeutics reports positive Phase 2 data for MZE829 in patients with AMKD
Thermo Fisher Scientific and SHL Medical launch integrated US drug-device manufacturing
Myosin Therapeutics granted USD2m funding from Florida Department of Health
Clover Biopharmaceuticals reports positive US Phase I data for RSV re-vaccination in older adults
Akeso's Phase II trials of AK146D1 and AK138D1 approved in China